These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 2955740)

  • 1. The perforant pathway in Down's syndrome.
    Mann DM; Yates PO
    Ann Neurol; 1987 Jun; 21(6):613-4. PubMed ID: 2955740
    [No Abstract]   [Full Text] [Related]  

  • 2. Perforant pathway changes and the memory impairment of Alzheimer's disease.
    Hyman BT; Van Hoesen GW; Kromer LJ; Damasio AR
    Ann Neurol; 1986 Oct; 20(4):472-81. PubMed ID: 3789663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The limbic system in Alzheimer's disease. A neuropathologic investigation.
    Hopper MW; Vogel FS
    Am J Pathol; 1976 Oct; 85(1):1-20. PubMed ID: 135514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease.
    Hyman BT; Kromer LJ; Van Hoesen GW
    Ann Neurol; 1987 Mar; 21(3):259-67. PubMed ID: 3606033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anterior commissure in Down's syndrome.
    Sylvester PE
    J Ment Defic Res; 1986 Mar; 30 ( Pt 1)():19-26. PubMed ID: 2939251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fine structural study of the hippocampus and dorsal root ganglion in mouse trisomy 16, a model of Down's syndrome.
    Lane NJ; Balbo A; Rapoport SI
    Cell Biol Int; 1996 Oct; 20(10):673-80. PubMed ID: 8969460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropathological study on progression of the limbic degeneration in senile dementia of Alzheimer type].
    Kasahara M; Mizutani T
    No To Shinkei; 1997 Jan; 49(1):51-8. PubMed ID: 9027902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus.
    Ferrer I; Gullotta F
    Acta Neuropathol; 1990; 79(6):680-5. PubMed ID: 2141748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The topography of plaques and tangles in Down's syndrome patients of different ages.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    Neuropathol Appl Neurobiol; 1986; 12(5):447-57. PubMed ID: 2946973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia.
    Ball MJ; Nuttall K
    Ann Neurol; 1980 May; 7(5):462-5. PubMed ID: 6446875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perforant pathway degeneration as a system degeneration: secondary hippocampal degeneration in Alzheimer-type dementia].
    Mizutani T
    No To Shinkei; 1998 Oct; 50(10):895-905. PubMed ID: 9842548
    [No Abstract]   [Full Text] [Related]  

  • 14. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced hippocampal functional connectivity in Alzheimer disease.
    Allen G; Barnard H; McColl R; Hester AL; Fields JA; Weiner MF; Ringe WK; Lipton AM; Brooker M; McDonald E; Rubin CD; Cullum CM
    Arch Neurol; 2007 Oct; 64(10):1482-7. PubMed ID: 17923631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathology of the human locus ceruleus.
    Mann DM; Yates PO; Hawkes J
    Clin Neuropathol; 1983; 2(1):1-7. PubMed ID: 6220852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in the human forebrain.
    Scheibel AB
    Neurosci Res Program Bull; 1982 Apr; 20(4):577-83. PubMed ID: 7121843
    [No Abstract]   [Full Text] [Related]  

  • 18. Alzheimer-type dementia and Down's syndrome: solubility of neurofibrillary tangles is related to duration of dementia.
    Hussey S; Yates CM; Christie JE; Elton RA; Gordon A
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):823-4. PubMed ID: 2956365
    [No Abstract]   [Full Text] [Related]  

  • 19. Compensating for Alzheimer lesions: evidence that size counts.
    Lippa CF
    Neurology; 2009 Sep; 73(9):656-7. PubMed ID: 19641170
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.